Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myopericarditis (MP), in patients treated with immune checkpoint inhibitors (ICIs), is still conflicting. We explored this issue through a global real-world approach.
Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., Diemberger, I. (2021). Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. VACCINES, 9(1), 1-13 [10.3390/vaccines9010019].
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
Gatti, Milo;Raschi, Emanuel;Ardizzoni, Andrea;Poluzzi, Elisabetta;Diemberger, Igor
2021
Abstract
Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myopericarditis (MP), in patients treated with immune checkpoint inhibitors (ICIs), is still conflicting. We explored this issue through a global real-world approach.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
vaccines-09-00019-v2.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
263.93 kB
Formato
Adobe PDF
|
263.93 kB | Adobe PDF | Visualizza/Apri |
|
vaccines-09-00019-s001.pdf
accesso aperto
Tipo:
File Supplementare
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
91.25 kB
Formato
Adobe PDF
|
91.25 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
